Dr. Mythily Srinivasan is a faculty researcher and associate professor at the Indiana University School of Dentistry with expertise in oral pathology, immunology, and immune therapeutics. She received her Ph.D. in immunology at Ohio State University. She is also a member of the American Association of Immunologists, American Cancer Society and the American Peptide Society. Her research contributions include publications on salivary biomarkers for oral and systemic diseases such as diabetes, as well as publications on immune therapeutics for autoimmune diseases (arthritis, colitis) and neurodegenerative pathologies (Alzheimer's disease and multiple sclerosis). She holds three patents for the development of novel therapeutic peptides that target the T-cell costimulatory pathway and peptides that target nuclear factor-kB p65 to suppress chronic inflammation.
Dr. Mythily Srinivasan is a faculty researcher and associate professor at the Indiana University School of Dentistry with expertise in oral pathology, immunology, and immune therapeutics. She received her Ph.D. in immunology at Ohio State University. She is also a member of the American Association of Immunologists, American Cancer Society and the American Peptide Society. Her research contributions include publications on salivary biomarkers for oral and systemic diseases such as diabetes, as well as publications on immune therapeutics for autoimmune diseases (arthritis, colitis) and neurodegenerative pathologies (Alzheimer's disease and multiple sclerosis). She holds three patents for the development of novel therapeutic peptides that target the T-cell costimulatory pathway and peptides that target nuclear factor-kB p65 to suppress chronic inflammation.